The knockdown of GIT1 in human osteosarcoma cells has shown in vivo and in vitro reduced tumour cell growth, invasion and angiogenesis, which could make GIT1 a potential target in gene therapy123. The gene discussed is GIT1; the disease is osteosarcoma.